4Abizaid AS,Mintz GS,Abizald A,et al.Influence of patient age on acute and late clinical outcomes follwing Palmaz-Schatz coronary stent implantation[J].Am J Cardiol,2000,85:338-343.
5Bolli tL Oxygen-derived free radicals and myocardial reperfusion in jury; an overviewf-.J]. Cardiovasc Drugs Ther, 1991,5: 249-268.
6W U MY, Tsai FC. Extracorporeal life support in resuscitat for a- cute myocardial infarction with cardiogenic shock[J]. Chang Gung Med J,2006,29(2) :207-211.
7马长生.冠脉介入治疗——技术与策略[M].北京:人民卫生出版社,2004:207-140.
8Califf RM,Abdelmegiuid AE,Kuntz,et al.Myonecrosis after revascularization procedures[J].J Am Coll Cardiol,1998,31:241-251.
9Kizer JR,Muttrej MR,Matthai WH,et al.Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention[J].Eur Heart J,2003,24:1314-1322.
10Wuc Hannan EL,Walford GA.Risk score to predict in-hospital mortality for percutaneous coronary interventions[J].J Am Coll Cardiol,2006,47 (3):650-660.
